BeOne Medicines Ltd.
ONC
$308.63
-$5.04-1.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7,326.77% | 100.91% | 7.44% | -25.35% | 52.06% |
| Total Depreciation and Amortization | -5.58% | -81.06% | 456.15% | -297.44% | -1.48% |
| Total Amortization of Deferred Charges | 390.11% | -75.20% | 304.51% | -296.47% | -0.51% |
| Total Other Non-Cash Items | 45.75% | -62.81% | 213.08% | -33.27% | 55.96% |
| Change in Net Operating Assets | 106.86% | 50.35% | -159.68% | 332.21% | 27.00% |
| Cash from Operations | 497.97% | -60.50% | -19.61% | 245.24% | 69.02% |
| Capital Expenditure | 22.30% | 35.73% | 42.14% | -37.95% | 29.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.24% | 58.93% | -200.26% | 14,808.01% | 97.97% |
| Cash from Investing | 45.38% | 50.69% | -3,415.17% | 106.72% | 47.09% |
| Total Debt Issued | 76.90% | -85.42% | 807.07% | -66.84% | 20.72% |
| Total Debt Repaid | 34.83% | 68.30% | -785.74% | 62.43% | -4,592.12% |
| Issuance of Common Stock | -47.69% | 1,545.00% | -97.60% | 2,780.82% | -62.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 113.77% | -5,472.58% | -- |
| Cash from Financing | 203.69% | -212.39% | 300.68% | -165.06% | -85.82% |
| Foreign Exchange rate Adjustments | 574.63% | 106.96% | -292.11% | 540.91% | 73.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 336.23% | 30.51% | -198.93% | 183.02% | 49.94% |